AL
The startup develops curative cell therapy medicines utilizing directed differentiation, forward programming, and tissue environment engineering to treat life-threatening metabolic and respiratory diseases. By transforming patient cells, the company aims to restore normal function and improve quality of life for individuals affected by these conditions.
Updated 3 months ago
Funding
$340K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops curative cell therapy medicines utilizing directed differentiation, forward programming, and tissue environment engineering to treat life-threatening metabolic and respiratory diseases. By transforming patient cells, the company aims to restore normal function and improve quality of life for individuals affected by these conditions.